The estimated Net Worth of Mary C Beckerle is at least $1.21 Million dollars as of 24 November 2020. Mary Beckerle owns over 15,251 units of Johnson & Johnson stock worth over $329,640 and over the last 14 years he sold JNJ stock worth over $537,754. In addition, he makes $344,979 as Independent Director at Johnson & Johnson.
Mary has made over 2 trades of the Johnson & Johnson stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 15,251 units of JNJ stock worth $399,119 on 24 November 2020.
The largest trade he's ever made was selling 15,251 units of Johnson & Johnson stock on 24 November 2020 worth over $399,119. On average, Mary trades about 706 units every 40 days since 2011. As of 24 November 2020 he still owns at least 2,000 units of Johnson & Johnson stock.
You can see the complete history of Mary Beckerle stock trades at the bottom of the page.
Dr. Mary C. Beckerle, Ph.D., is an Independent Director of the Company. She has served as Chief Executive Officer of the Huntsman Cancer Institute at the University of Utah since 2006. She is the Associate Vice President for Cancer Affairs and a Distinguished Professor of Biology and Oncological Sciences at the University of Utah. Dr. Beckerle joined the faculty of the University of Utah in 1986 and currently holds the Jon M. Huntsman Presidential Endowed Chair. Dr. Beckerle has served on the National Institute of Health (NIH) Advisory Committee to the Director, on the Board of Directors of the American Association for Cancer Research, as President of the American Society for Cell Biology and as the Chair of the American Cancer Society Council for Extramural Grants. She currently serves on a number of scientific advisory boards, including the Medical Advisory Board of the Howard Hughes Medical Institute, the Board of Scientific Advisors of the National Cancer Institute (USA) and the External Advisory Board of the Dana Farber/Harvard Cancer Center.
As the Independent Director of Johnson & Johnson, the total compensation of Mary Beckerle at Johnson & Johnson is $344,979. There are 14 executives at Johnson & Johnson getting paid more, with Alex Gorsky having the highest compensation of $25,365,800.
Mary Beckerle is 65, he's been the Independent Director of Johnson & Johnson since 2015. There are 7 older and 25 younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Ronald Williams, 70, who is the Independent Director.
Over the last 22 years, insiders at Johnson & Johnson have traded over $59,929,946 worth of Johnson & Johnson stock and bought 21,998 units worth $2,578,685 . The most active insiders traders include Hubert Joly, Anne M Mulcahy, and Alex Gorsky. On average, Johnson & Johnson executives and independent directors trade stock every 21 days with the average trade being worth of $4,572,436. The most recent stock trade was executed by Robert J Decker on 30 August 2024, trading 5,635 units of JNJ stock currently worth $563,838.
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson executives and other stock owners filed with the SEC include: